Print

ZymoGenetics, Inc. (ZGEN) (JOBS) Says Merck Serono Discontinues MS Trials  
9/28/2009 6:27:01 AM

Bookmark and Share

Reuters -- Biotechnology firm Zymogenetics Inc said its licensee, Merck Serono SA, discontinued trials of its experimental drug, atacicept, for the treatment of multiple sclerosis (MS).

//-->